Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEST: Enecadin in Acute Ischemic Stroke
NCT00331721Phase 2Terminated
- Sponsor
- PAION AG
- Start
- May 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing Enecadin with Placebo (2 arms). Primary endpoints: Safety parameters at 1 month, Pharmacokinetics at 1 month and 1 more. Started May 2006; status: terminated.
02
Drugs
enecadin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00331721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331721.